0001567619-18-008657.txt : 20181226
0001567619-18-008657.hdr.sgml : 20181226
20181226184516
ACCESSION NUMBER: 0001567619-18-008657
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181220
FILED AS OF DATE: 20181226
DATE AS OF CHANGE: 20181226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PARTRIDGE JOHN
CENTRAL INDEX KEY: 0001319897
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-08323
FILM NUMBER: 181253451
MAIL ADDRESS:
STREET 1: 123 MISSION STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cigna Holding Co
CENTRAL INDEX KEY: 0000701221
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
IRS NUMBER: 061059331
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 COTTAGE GROVE ROAD
CITY: BLOOMFIELD
STATE: CT
ZIP: 06002
BUSINESS PHONE: 8602266000
MAIL ADDRESS:
STREET 1: 900 COTTAGE GROVE ROAD
CITY: BLOOMFIELD
STATE: CT
ZIP: 06002
FORMER COMPANY:
FORMER CONFORMED NAME: CIGNA CORP
DATE OF NAME CHANGE: 20111020
FORMER COMPANY:
FORMER CONFORMED NAME: Cigna Corp
DATE OF NAME CHANGE: 20111019
FORMER COMPANY:
FORMER CONFORMED NAME: CIGNA CORP
DATE OF NAME CHANGE: 19920703
4
1
doc1.xml
FORM 4
X0306
4
2018-12-20
1
0000701221
Cigna Holding Co
CI
0001319897
PARTRIDGE JOHN
900 COTTAGE GROVE ROAD
BLOOMFIELD
CT
06002
1
0
0
0
Common Stock, $.25 Par Value
2018-12-20
4
D
0
32580
0
D
0
D
Common Stock, $.25 Par Value
2018-12-20
4
D
0
1620
0
D
0
I
By Trust
Reflects disposition in connection with the consummation of the mergers (collectively, the "Merger") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) ("Cigna"), Express Scripts Holding Company ("Express Scripts"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger ("New Cigna"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the "Merger Agreement"), pursuant to which, at the effective time of the Merger (the "Effective Time"), (continued in following footnote)
(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share ("Cigna Common Stock"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna ("New Cigna Common Stock"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30.
/s/ Jill M. Stadelman, attorney-in-fact
2018-12-26